ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
ICP Monitoring Devices Market Report Overview
The ICP monitoring devices market was valued at $163.7 million in 2023. The market will grow at a CAGR of more than 2% from 2023 to 2033. In most countries, traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. Measurement of ICP helps in the detection of brain damage and initiation of therapeutic intervention. ICP monitoring using External Ventricular Drainage (EVD) is considered the gold standard as the technique allows an additional therapeutic function of CSF drainage.
ICP Monitoring Devices Market Outlook 2023-2033 ($ Million)
Buy the Full Report for Detailed Insights on the ICP Monitoring Devices Market Forecast,
Download a Free Sample Report
The ICP monitoring devices market research report explains the market behavior, which will help identify quantitative market trends within the neurology devices therapeutic area. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies. The model also discusses the detailed impact of COVID-19 on the ICP monitoring devices market for 2020 and beyond.
Market Size (2023) | $163.7 million |
CAGR (2023-2033) | >2% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
ICP Monitoring Devices Market Dynamics
The ICP monitoring market will grow over the forecast period, primarily driven by an increase in the patient population with traumatic brain injury, hydrocephalus, and other neurological disorders. KOLs have indicated that purchasing decisions are usually influenced by surgeon familiarity with the product, clinical outcomes associated with the device, and the cost of the device. Among the different types of devices tracked in the model, the use of antimicrobial EVD will continue to rise in the forecast period.
ICP Monitoring Devices Market Segmentation by Segments
The key segments in the ICP monitoring devices market are external ventricular drainage (EVD) and microtransducer devices. In 2023, the external ventricular drainage (EVD) segment accounted for the largest ICP monitoring devices market share. This segment is further categorized into antimicrobial EVD and regular EVD. Of these, the antimicrobial EVD sub-segment led the market in 2023.
ICP Monitoring Devices Market Analysis by Segments, 2023 (%)
Buy the Full Report for more Segment-Wise Insights into the ICP Monitoring Devices Market, Download a Free Sample Report
ICP Monitoring Devices Market Segmentation by Regions
The key regions in the ICP monitoring devices market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America.
North America had exhibited strong adoption of ICP monitoring devices compared to other regions and had the largest share of the global market in 2023. The other reasons for market dominance include increased hospital infrastructure and a larger patient population base. The North American ICP market is expected to grow during the forecast period, largely due to increases in ICP procedural numbers, driven by aging populations.
ICP Monitoring Devices Market Analysis by Regions, 2023 (%)
Buy the Full Report for more Regional Insights into the ICP Monitoring Devices Market, Download a Free Sample Report
ICP Monitoring Devices Market – Competitive Landscape
The key companies in the ICP monitoring devices market are Integra LifeSciences Corp, Medtronic plc, Natus Medical Inc., Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, and Hpbio among others. In 2023, Integra LifeSciences Corp accounted for the highest ICP monitoring devices market share and value.
ICP Monitoring Devices Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More About Leading ICP Monitoring Devices Market Players
Download a Free Sample Report
Segments Covered in this Report
ICP Monitoring Devices Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
ICP Monitoring Devices Segment Outlook ($ Million, 2015-2033)
- External Ventricular Drainage (EVD)
- Antimicrobial EVD
- Regular EVD
- Microtransducer Devices
Key Inclusions of the market model are:
Currently marketed ICP monitoring devices market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total ICP monitoring devices market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the ICP monitoring devices market.
- Competitive dynamics insights and trends provided for the ICP monitoring devices market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Integra LifeSciences Corp, Medtronic plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, Hpbio, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives must have a deep understanding of the ICP monitoring devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on ICP monitoring devices.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving ICP monitoring devices.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ICP monitoring devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific ICP monitoring devices market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Medtronic plc
Natus Medical Inc
Spiegelberg GmbH & Co KG
Sophysa SA
Raumedic AG
Hpbio
Others
Frequently asked questions
-
What is the ICP monitoring devices market size in 2023?
The ICP monitoring devices market size will be $163.7 million in 2023.
-
What will the ICP monitoring devices market CAGR be from 2023 to 2033?
The market will grow at a CAGR of more than 2% from 2023 to 2033.
-
Which region dominated the ICP monitoring devices market in 2023?
North America was the largest regional segment of the ICP monitoring devices market in 2023.
-
Which segment led the ICP monitoring devices market in 2023?
In 2023, the external ventricular drainage (EVD) segment accounted for the largest ICP monitoring devices market share.
-
Which are the key companies operating in the ICP monitoring devices market?
The key companies in the ICP monitoring devices market are Integra LifeSciences Corp, Medtronic plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, Hpbio, and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.